Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phrase "CD8+ T cell infiltration/activation" refers to the multi-step immunological process where CD8-positive cytotoxic T lymphocytes migrate from the bloodstream into tissues such as tumors, followed by activation through three main signals: antigen recognition by the T cell receptor (TCR), co-stimulatory signals (primarily via CD28), and cytokine signaling. This activation results in effector functions such as direct killing of infected or malignant cells, secretion of cytokines, and orchestration of broader immune responses. The presence and activity of CD8+ T cells within tumors is a key determinant of effective anti-tumor immunity and is predictive of response to immunotherapy[1][3][4][5]. Mechanisms regulating this process include adhesion and integrin interactions for infiltration, three-signal paradigms for activation, and checkpoints (PD-1, CTLA-4, etc.) that limit overactivation and maintain self-tolerance[1][4].
Enhancement of T cell activation, inhibition of co-inhibitory receptors (e.g., anti-PD-1/PD-L1, anti-CTLA-4), stimulation with cytokines, adoptive transfer of activated T cells
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD8-positive T cell infiltration and activation (null).